BioCentury
ARTICLE | Finance

Ebb & Flow

January 20, 2003 8:00 AM UTC

Amylin

(AMLN) had a quick turnaround on its follow-on, raising $152.7 million in a bumped-up deal in which it sold 9.2 million shares at $16.60. Time will tell whether the deal will break the ice for other offerings, but the quick pricing and lack of a haircut certainly indicate improved investor sentiment. ...